These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 5975305)

  • 21. [Results of the treatment in patients with pulmonary tuberculosis excreting bacilli in primary resistance to antitubercular drugs].
    Hornung S; Polończyk M
    Gruzlica; 1965 Oct; 33(10):886-9. PubMed ID: 5881604
    [No Abstract]   [Full Text] [Related]  

  • 22. [Early and late results of treatment of patients with tuberculosis shedding mycobacteria with primary resistance to basic antituberculous drugs].
    Dubrawska H; Gryziecka T; Maceluch-Wojtkowa M; Orzechowska W
    Wiad Lek; 1968 Jan; 21(2):77-80. PubMed ID: 5671874
    [No Abstract]   [Full Text] [Related]  

  • 23. [Criteria of inactivity in pulmonary tuberculosis after correct chemotherapy].
    Bek E; Bukalska Z; Stachlewska S; Zachara A
    Gruzlica; 1968 Oct; 36(10):897-907. PubMed ID: 5710094
    [No Abstract]   [Full Text] [Related]  

  • 24. [Pharmacoresistance to anti-tubercular chemical antibiotics and tuberculin reactivity].
    Vercellino A; Galietti F; Giorgis GE; Ferrua M; Ardizzi A
    Arch Sci Med (Torino); 1980; 137(4):745-7. PubMed ID: 7247697
    [No Abstract]   [Full Text] [Related]  

  • 25. [Specific serum antimycobacterial activity test in pulmonary tuberculosis patients].
    Yamagata Y; Konomata T
    Iryo; 1966 May; 20(5):450-5. PubMed ID: 5963052
    [No Abstract]   [Full Text] [Related]  

  • 26. [Results of treatment in new cases of pulmonary tuberculosis registered in 1963 at the Antitubercular Dispensary of the Wola District of Warsaw].
    Rose A
    Gruzlica; 1967 Dec; 35(12):1251-6. PubMed ID: 6081907
    [No Abstract]   [Full Text] [Related]  

  • 27. [Tuberculosis and cancer: primary lung cancer cases after treatment with anti-tuberculous drugs].
    Sato H; Kayaba K; Oizumi K; Motomiya M
    Kekkaku; 1989 Jul; 64(7):465-9. PubMed ID: 2585947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of primary and acquired resistance of Mycobacterium tuberculosis to antituberculosis drugs in Benin after 12 years of short-course chemotherapy.
    Trébucq A; Anagonou S; Gninafon M; Lambregts K; Boulahbal F
    Int J Tuberc Lung Dis; 1999 Jun; 3(6):466-70. PubMed ID: 10383057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The present situation, treatment and prognosis of drug-resistant pulmonary tuberculosis. Cooperative Study Unit of Chemotherapy of Tuberculosis of the National Sanitoria in Japan].
    Sato K; Nagai H; Kurashima A; Mori M; Katayama T
    Kekkaku; 1995 Oct; 70(10):585-9. PubMed ID: 8523851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Residual pulmonary lesions after standard chemotherapy of advanced cavernous tuberculosis].
    Krychniak W; Pszonicka A; Zajaczkowska J
    Gruzlica; 1967 Jun; 35(6):519-27. PubMed ID: 6051994
    [No Abstract]   [Full Text] [Related]  

  • 31. [Fate of patients with "open negative" syndrome].
    Frenkel S; Wójcik B; Jaworski J
    Gruzlica; 1968 May; 36(5):451-4. PubMed ID: 5660491
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prolonged chemotherapy in dispensary patients with fibro-cavernous pulmonary tuberculosis].
    Khudushina TA
    Probl Tuberk; 1967; 45(6):46-51. PubMed ID: 5604889
    [No Abstract]   [Full Text] [Related]  

  • 33. [Sources of tuberculous infection in the incidence of lung tuberculosis in Middle-Bohemian Region in 1967 (author's transl)].
    Véznerová A; Polánský F
    Cesk Epidemiol Mikrobiol Imunol; 1974 May; 23(3):150-9. PubMed ID: 4280953
    [No Abstract]   [Full Text] [Related]  

  • 34. Anti-tuberculosis drug resistance in Madagascar in 1994-1995.
    Chanteau S; Rasolofo V; Ramarokoto H; Rasolonavalona T; Ratsirahonana O; Ratsitorahina M; Rakotomanana F; Boisier P; Cauchoix B; Aurégan G
    Int J Tuberc Lung Dis; 1997 Oct; 1(5):405-10. PubMed ID: 9441093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical manifestations and specific features of the course of adenogenic tuberculosis in adults].
    Ozerova LV; Zaĭtseva IP; Chistiakova NA
    Probl Tuberk; 2003; (3):42-5. PubMed ID: 12744064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Morphology of pulmonary tuberculosis following systematic long term antibacterial therapy].
    Vavilin GI; Raskina ES
    Probl Tuberk; 1969; 47(4):48-52. PubMed ID: 5368445
    [No Abstract]   [Full Text] [Related]  

  • 37. [Chemotherapy of tuberculosis].
    Rev Port Pediatr Pueric; 1965 Nov; 28(11):306-14. PubMed ID: 5295697
    [No Abstract]   [Full Text] [Related]  

  • 38. [Current incidence of primary resistance in hospitals].
    Girbal JP; Orlando JP; Taranger J; Charpin J
    Mars Med; 1972; 109(11):776-8. PubMed ID: 4662244
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical importance of primary resistance to major drugs in pulmonary tuberculosis patients].
    Balestrino E; Pio A
    Torax; 1967 Jun; 16(2):64-9. PubMed ID: 5614163
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical experiences with the new antitubercular agent Myambutol].
    Kilic S
    Med Klin; 1968 Dec; 63(51):2082-5. PubMed ID: 5730449
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.